Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 12/15/2011 9:25:29 PM : Outperform Start Price: $3.10 AMRI Score: -16.48

There are currently 4500 AMRI shares in my "fund" with break-even of around 3.75 USD.
http://caps.fool.com/Blogs/fund-trades/678775.

Report this Post 1 Comment
Member Avatar portefeuille (99.75) Submitted: 2/9/2012 12:48:20 AM
Recs: 0

now 5200 shares in the fund with break-even of around 8.54 USD.
http://caps.fool.com/Blogs/fund-trades/705717.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement